General presentation of Vertex Pharmaceuticals :
We now invite you to discover a little more information about Vertex Pharmaceuticals and its activities. Indeed, it is essential that you understand how this group generates its revenues before speculating on its share price.
The Vertex Pharmaceuticals group is a US company specialising in the research, development and marketing of micro-molecular drugs, particularly for the treatment of certain cancers, viral diseases, inflammatory diseases and autoimmune diseases.
In order to better understand Vertex's activities, they can be divided into different divisions according to the share of turnover they generate :
- The sale of products represents the major part of this group's revenue with 99.9% of turnover.
- This is followed by royalties and income from partnership, research and development agreements for 0.1% of turnover.
The geographical distribution of this group's revenues is also interesting to know and it should be noted that Vertex achieves 73.6% of its turnover in the United States, 21.3% in Europe and 5.1% in the rest of the world.
To know the competition of Vertex Pharmaceuticals shares :
Although the Vertex Pharmaceuticals group is currently one of the leaders in its sector, particularly in the US market, it is of course not the only one in the sector and faces relatively strong competition. Here are its main opponents:
- Abbot Laboratories: This American pharmaceutical company founded in 1888 is a major pharmaceutical industry in the United States and currently employs more than 90,000 people.
- AbbVie: This other American company specialising in pharmaceutical research is active in the development of therapeutic drugs to treat rheumatoid arthritis, psoriasis, Crohn's disease, thyroid problems, Parkinson's disease, HIV or certain complications of cystic fibrosis, low testosterone levels or complications of kidney disease.
- Allergan Inc : This American pharmaceutical laboratory specialises in ophthalmology, neurology and dermatology products. It is known for having created Botox.
- Amgen: This company created in 1980 is a leader in the medical biotechnology industry and is an American company based in California.
- Biogen: Biogen is a US company dating from 2003 and created by the merger of two world leaders in biotechnology, namely Biogen Inc and IDEC Pharmaceuticals Corporation.
- Eli Lilly & Co: This other American pharmaceutical group is currently one of the largest in its sector in terms of turnover.
- Gilead Sciences: Finally, the last serious competitor of Vertex Pharmaceuticals is the American group Gilead Sciences which specialises in pharmaceuticals and develops similar products.
The strategic alliances set up by the Vertex Pharmaceuticals group :
Although there are unfortunately few examples of recent partnerships on the part of the Vertex Pharmaceuticals group, we can however talk here about an agreement recently concluded with the Australian government, the details of which we will give you here.
In 2018, Vertex Pharmaceuticals announced an agreement with the Australian government to reimburse ORKAMBI for 6-year-olds with cystic fibrosis who have two copies of the F505del mutation in the transmembrane conductance regulator gene for cystic fibrosis. As a result of this agreement, this treatment will be included in the drug plan from 1 October this year 2018 and following a positive recommendation from Australia's Pharmaceutical Benefits Advisory Committee. Indeed, access to the future treatment being discussed here is being established as part of this process.
It goes without saying that future partnerships are likely to occur in the coming months or years.